FDA-approved therapy that delivers high-concentration oxygen directly to the heart muscle during heart attack treatment, reducing heart damage and improving recovery.
Heart attack patient receiving primary PCI
(Angioplasty)
SSO₂ Therapy is an additional treatment used after the blocked artery has been reopened through angioplasty and stenting.
It works by delivering very high levels of oxygen directly to the heart muscle through the patient’s own blood. This helps support areas of the heart that may still not receive enough oxygen even after the artery is cleared.
The therapy is performed in the cardiac catheterisation laboratory immediately after angioplasty and does not delay emergency treatment.
Relatively reduced heart
muscle damage by up to 26%
Faster Recovery
Better long-term heart
function
Available immediately during
emergency treatment
SuperSaturated Oxygen (SSO₂) Therapy is an advanced treatment that helps the heart recover after a severe heart attack. It is used together with angioplasty and stenting to deliver extra oxygen directly to the heart muscle, supporting healing and reducing long-term damage.
A heart attack happens when blood flow to the heart muscle is suddenly blocked, usually by a clot in a coronary artery. Without oxygen, the heart muscle can quickly become damaged.
One of the most serious heart attacks involves the left anterior descending (LAD) artery, which supplies blood to a large portion of the heart. Because of its severity, it is sometimes referred to as a “widowmaker” heart attack.
Fast treatment is crucial. The longer the heart muscle goes without oxygen, the greater the risk of permanent damage.
No. Angioplasty and stenting remain the primary treatment for heart attacks.
SSO₂ Therapy is an additional treatment used after the artery has been successfully reopened to help the heart recover.
